Received May 22, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
He reported experiencing chills about 6 hours after both doses of Shingrix; This non-serious case was reported by a nurse via sales rep and described the occurrence of chills in a adult male patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of chills (1st dose received on an unknown date). On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 6 hrs after receiving Shingrix, the patient experienced chills (Verbatim: He reported experiencing chills about 6 hours after both doses of Shingrix). Rechallenge with Shingrix was positive. The outcome of the chills was not reported. It was unknown if the reporter considered the chills to be related to Shingrix. It was unknown if the company considered the chills to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR063168 Additional Information: GSK Receipt Date: 20-MAY-2025 The patient experiencing chills about 6 hours after both doses of Shingrix.; Sender's Comments: US-GSK-US2025AMR063168:Same patient/another dose